Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Lithium Hydroxide | HCID 3939 | — |
| Reactant | 4-Methylmorpholine | HCID 7972 | — |
| Reactant | P,P-Diphenylphosphinic azide | HCID 199401 | — |
| Reactant | HCID 68959411 | HCID 68959411 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 86616777 | HCID 86616777 | 31.9% |
Reaction Steps
Lithium hydroxide (63 mg, 1.49 mmol) was added to a solution of methyl N-(tert-butoxycarbonyl)-S-{2-[(cyclopropylmethyl)amino]-1-phenylethyl}-D-cysteinate (507 mg, 1.24 mmol) in tetrahydrofuran (10 mL) and water (2 mL). After 1 h, then mixture was concentrated and azeotroped with toluene (3×) to give the crude acid. Diphenylphosphoryl azide (0.53 ml, 2.48 mmol) was added to a solution of the crude acid and 4-methylmorpholine (0.20 mL, 1.86 mmol) in N,N-dimethylformamide (25 mL). After 4 h, the mixture was concentrated and water was added. The mixture was extracted with ethyl acetate, and the organic layer was washed with water (2×) and saturated brine, dried over magnesium sulfate, filtered, and concentrated. Purification by silica gel chromatography (5% ethyl acetate/hexanes→20% ethyl acetate/hexanes) gave the title compound (149 mg). MS 377 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07491713B2 |
|---|
| Source dataset | uspto-grants-2009_02 |
|---|
| ORD ID | ord-19d9504fbb4b4b9f997d361f57c58241 |
|---|
| Source note | uspto-grants-2009_02 |
|---|